Shows / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes…
Episodes
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the ongoing GLP-1 RA shortage and whether or not…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: EASD 2022 and Recent CGM News
In this special edition episode of Diabetes Dialogue, our hosts break down their top clinical takeaways from the European Association for the Study of Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: September 2022
In the September 2022 episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: ADCES 2022 Recap
In this episode of Diabetes Dialogue, which was filmed days after the conclusion of ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD
In this edition of Diabetes Dialogue, which was filmed on-site at ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with Jennifer…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Sit Down with Diabetes Care and Education Specialist of the Year, Anastasia Albanese-O'Neill, PhD
In this episode, the hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with ADCES 2022 Diabetes Care and Education Specialist of the Year…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: T1D Exchange, with David Walton
In this ADCES 22 special edition episode of Diabetes Dialogue, our hosts are joined by David Walton, CEO of the T1D Exchange, who takes our hosts on a deep…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Exploring DiabetesWise, with Korey Hood, PhD
In this special edition of Diabetes Dialogue recorded on-site at ADCES 22, our hosts are joined by Korey Hood, PhD, a staff pscyhologist and professor at…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: The Race to Cure T1D
For the July 2022 episode of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, & Misdiagnosis of T1D
In this edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives our hosts discuss the experiences of their prescribing tirzepatide…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Inside ADA 2022
In the fourth and final episode from ADA 2022, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the meeting from their perspectives…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmD
In the third special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, Dr. Jasmine Gonzalvo, director of…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE
In our second special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, hosts Drs. Diana Isaacs and…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Optimizing CGM Uptake in Primary Care
In the first of 4 special edition ADA 2022 episodes, hosts Drs. Diana Isaacs and Natalie Bellini take on the role of interviewers and discuss CGM uptake in…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Tirzepatide in Action & AACE 2022 Recap
In this episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: ATTD 2022 Recap
In this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, BCPS, BC-ADM, BCACP…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: April 2022
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
The inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSemaglutide 2.4 mg (Wegovy):A Turning Point for Obesity
Ahead of ADA 2021, Dr. Thomas Wadden discusses the significance of the Wegovy approval for chronic weight management and Novo Nordisk's plans to evaluate an…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSubcutaneous Semaglutide for Weight Loss with Thomas Wadden, PhD
This episode of the Endocrine Outlook podcast features Thomas Wadden, PhD, a professor of psychology at Perelman School of Medicine at the University of Penn…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesTirzepatide for Weight Loss and Lowering HbA1c with Juan Frias, MD
This episode of the Endocrine Outlook features a conversation with Juan Frias, MD, medical director of the National Research Institute. Frias is also the…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP
In this episode, Endocrinology Network senior editor Patrick Campbell speaks with Dr. Ariana Chao, of Penn Nursing, about dietary interventions and nutrition…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesJeffrey Curtis, MD: Osteoporosis in 2020
This episode of the Endocrine Outlook features a recent interview with Dr. Jeffrey Curtis, of the University of Alabama at Birmingham. A rheumatologist and…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesOsilodrostat and Treatment of Cushing's Disease
Dr. Georgiana Dobri, a neuroendocrinologist with Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesTerri Lipman, PhD, CRNP: Addressing Racial Disparities in Medicine
This episode of the Endocrine Outlook features a conversation with Terri Lipman, PhD, CRNP, of the University of Pennsylvania. In the interview, Lipman…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesRaymond Douglas, MD, PhD: State of Thyroid Eye Disease in 2020
Raymond Douglas, MD, PhD, discusses trends in therapies and the current state of thyroid eye disease treatments in 2020.
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesMuthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs
In this episode of the Endocrine Outlook, listeners will hear a conversation with Muthiah Vaduganathan, MD, MPH, a cardiologist at Brigham and Women’s…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesProf. Hiddo Heerspink: Insights from DAPA-CKD
In this special edition episode of the Endocrine Outlook, you will hear from Professor Hiddo Heerspink. Heerspink recently presented results of the DAPA-CKD…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesJoshua Denson, MD: Metabolic Syndrome and COVID-19 Outcomes
In this episode of the endocrine outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results of a…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesRobert Busch, MD: Topline Results of EMPEROR-REDUCED
In this episode we will be discussing reaction to topline results from the EMPEROR-REDUCED trial examining the use of empagliflozin for heart failure in…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Research & COVID-19
In this episode you’ll hear my interview with Dr. Jamie Hartmann-Boyce, senior research fellow and departmental lecturer at the Nuffield Department of Primary…